Jane Street Group, LLC Age X Therapeutics, Inc. Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.33 - $0.74 $3,808 - $8,541	11,542 New	11,542 $4,000
Q1 2022 May 17, 2022	SELL	$0.65 - $1.2 $18,275 - $33,739	-28,116 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$0.53 - $1.09 $14,901 - $30,646	28,116 New	28,116 $31,000
Q3 2019 Nov 14, 2019	SELL	$1.96 - $3.38 $53,127 - $91,618	-27,106 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$2.58 - $4.92 $69,933 - $133,361	27,106 New	27,106 $99,000
Q1 2019 May 16, 2019	SELL	$3.0 - $4.85 $69,735 - $112,738	-23,245 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$2.49 - $5.5 $57,880 - $127,847	23,245 New	23,245 $70,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.